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General Information.  Commercial reagents were purified prior to use following the
guidelines of Perrin and Armarego.1  Organic solutions were concentrated under reduced
pressure on a Büchi rotary evaporator.  Methylene chloride was distilled from calcium hydride
prior to use. Chromatographic purification of products was accomplished using forced-flow
chromatography on ICN 60 32-64 mesh silica gel 63 according to the method of Still.2  Thin-
layer chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.
Visualization of the developed chromatogram was performed by fluorescence quenching or
anisaldehyde stain.
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75 MHz
respectively) as noted, and are internally referenced to residual protio solvent signals.  Data for
1H are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t =
triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and assignment.  Data for
13C NMR are reported in terms of chemical shift.  IR spectra were recorded on a Perkin Elmer
Paragon 1000 spectrometer and are reported in terms of frequency of absorption (cm-1).  Mass
spectra were obtained from the UC Irvine Mass Spectral facility. High performance liquid
chromatography (HPLC) was performed on Hewlett-Packard 1100 Series chromatographs using
                                                 
1Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pregamon Press, Oxford, 1988.
2Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923.
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Chiralcel AD column (1.6 x 25 cm) and AD guard (1.6 x 5 cm), Chiralcel OD−H (1.6 x 25 cm)
and OD guard (1.6 x 5 cm), or Chiralcel AS (1.6 x 25 cm) and AS guard (1.6 x 5 cm) as noted.
General Procedure:  An amber 2-dram vial equipped with a magnetic stir bar and
containing (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one was charged with CH2Cl2,
isopropanol, and the appropriate acid, then placed in a bath of a desired temperature.  The
solution was stirred for 5 min before addition of the α,β-unsaturated aldehyde.  After stirring for
an additional 10 minutes the indole substrate was added in one portion. The resulting suspension
was stirred at constant temperature until complete consumption of the indole as determined by
TLC.  The reaction mixture was then passed cold through a silica gel plug with Et2O and then
concentrated. The resulting residue was purified by silica gel chromatography (solvents noted) to
afford the title compounds.  The enantioselectivity was determined by subjecting approximately
10 mg of the title compound to an excess of NaBH4 and 1 mL of ethanol.  After 15 min, the
solution was treated with saturated aqueous NaHCO3, and the mixture was extracted with
CH2Cl2.  The organic layer was separated, filtered through a silica gel plug and subjected to
chiral HPLC analysis (conditions noted).
(R)-3-(1-Methyl-1H-indol-3-yl)-butanal (Table 1, entry 6).  Prepared according to the
general procedure from crotonaldehyde (125 µL, 1.50 mmol), 1-methyl-1H-indole (64 µL, 0.50
mmol), TFA (7.7 µL, 0.10 mmol) and (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-
one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.85 mL) and isopropanol (0.15 mL) at −83 °C for 19 h to
provide, after silica gel chromatography (benzene), the title compound as a colorless oil (83 mg,
82% yield, 92% ee). IR (film) 3054, 2960, 2824, 2722, 1720, 1616, 1550, 1474, 1374, 1329,
1241, 740 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.75 (dd, J = 2.1, 2.1 Hz, 1H, CHO), 7.63 (d, J =
7.8 Hz, 1H, ArH), 7.32-7.21 (m, 2H, ArH), 7.12 (ddd, J = 1.5, 7.4, 8.1 Hz, 1H, ArH), 6.84 (s,
1H, NCH), 3.75 (s, 3H, NCH3), 3.68 (dt, J = 6.9, 13.8 Hz, 1H, ArCH), 2.88 (ddd, J = 2.7, 6.9,
16.2 Hz, 1H, CH2CO); 2.71 (ddd, J = 2.7, 6.9, 16.2 Hz, 1H, CH2CO); 1.44 (d, J = 7.2 Hz, 3H,
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CHCH3); 13C NMR (75 MHz, CDCl3) δ 202.8, 137.2, 126.6, 125.2, 121.8, 119.1, 118.9, 118.8,
109.5, 51.2, 32.8, 26.0, 21.9;  HRMS (CI) exact mass calcd for (C13H15NO) requires m/z
201.1154, found m/z 201.1152. [α]D = −  4.2 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde,
using a Chiracel AD and AD guard column (2:98 ethanol/hexanes, 1 mL/min); S isomer tr = 25.2
min and R isomer tr = 27.8 min.
(R)-3-(1-Methyl-1H-indol-3-yl)-hexanal (Table 2, entry 2). Prepared according to the
general procedure from 2-hexenal (174 µL, 1.50 mmol), 1-methyl-1H-indole (64µL, 0.50 mmol),
TFA (7.7 µL, 0.10 mmol) and (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (24.6
mg, 0.100 mmol) in CH2Cl2 (0.85 mL) and isopropanol (0.15 mL) at −60 °C for 6 h to provide,
after silica gel chromatography (5:95 EtOAc/hexanes),  the title compound as a colorless oil (92
mg, 80% yield, 93% ee). IR (film) 2959, 2923, 2870, 1720, 1483, 1470, 1425, 1376, 1327, 1244,
1159, 1132, 1016, 734 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.71 (dd, J = 2.1, 2.1 Hz, 1H, CHO),
7.67 (d, J = 8.4 Hz, 1H, ArH), 7.35-7.24 (m, 2H, ArH), 7.12 (ddd, J = 1.5, 7.2, 8.1 Hz, 1H,
ArH), 6.87 (s, 1H, NCH), 3.76 (s, 3H, NCH3), 3.55 (m, 1H, ArCH), 2.83 (m, 2H, CH2CO), 1.79
(m, 2H, CHCH2CH2), 1.34 (dt, J = 7.2, 22.8 Hz, 2H, CHCH2CH3), 0.92 (dd, J = 7.2, 7.2 Hz, 3H,
CH2CH3); 13C NMR (75 MHz, CDCl3) δ 203.0, 137.2, 127.0, 126.0, 121.6, 119.2, 118.7, 117.0,
109.4, 49.7, 38.5, 32.8, 31.4, 20.8, 14.2; HRMS (CI) exact mass calcd for (C15H19NO) requires
m/z 229.1467, found m/z 229.1464. [α]D = − 1.7 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde,
using a Chiracel AS and AS guard column (2:98 ethanol/hexanes, 1 mL/min); S isomer tr = 16.1
min and R isomer tr = 18.1 min.
(S)-4-Methyl-3-(1-methyl-1H-indol-3-yl)-pentanal (Table 2, entry 3). Prepared
according to the general procedure from 4-methyl-2-pentenal (175 µL, 1.50 mmol), 1-methyl-
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1H-indole (64µL, 0.50 mmol), TFA (7.7 µL, 0.10 mmol) and (2 S,5S)-5-benzyl-2-tert-butyl-3-
methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.90 mL) and isopropanol (0.10
mL) at −50 °C for 32 h to provide, after silica gel chromatography (10:90 EtOAc/hexanes), the
title compound as a colorless oil (85 mg, 74% yield, 93% ee). IR (film) 3052, 2958, 2870, 2834,
2716, 1723, 1609, 1546, 1482, 1469, 1423, 1373, 1328, 1246, 1160, 1138, 1015, 743 cm-1; 1H
NMR (300 MHz, CDCl3) δ 9.61 (dd, J = 2.4, 2.4 Hz, 1H, CHO), 7.63 (dt, J = 0.9, 8.1 Hz, 1H,
ArH), 7.33-7.22 (m, 2H, ArH), 7.13 (ddd, J = 1.5, 6.9, 8.1 Hz, 1H, ArH), 6.82 (s, 1H, NCH),
3.75 (s, 3H, NCH3), 3.40 (dt, J = 6.6, 7.8 Hz, 1H, ArCH), 2.81 (d, J = 2.4 Hz, 1H, CH2CO); 2.79
(d, J = 2.4 Hz, 1H, CH2CO); 2.10 (ddd, J = 6.6, 13.2, 19.8 Hz, 1H, CH(CH3)2, 0.96 (d, J = 2.1,
3H, CH(CH3)2, 0.94 (d, J = 2.1 Hz, 3H, CH(CH3)2; 13C NMR (75 MHz, CDCl3) δ 203.4, 137.0,
127.6, 126.7, 121.6, 119.4, 118.8, 115.6, 109.3, 46.1, 38.0, 32.9, 32.9, 20.6, 20.4; HRMS (CI)
exact mass calcd for (C15H19NO) requires m/z 229.1467, found m/z 229.1465. [α]D = + 15.8 (c =
1.0, CHCl3).  The enantiomeric ratio was determined by HPLC analysis of the alcohol, obtained
by NaBH4 reduction of the aldehyde, using a Chiracel AS and AS guard column (4% ethanol /
hexanes, 1 mL/min); R isomer tr = 13.4 min and S isomer tr = 16.7 min.
(S)-3-(1-Methyl-1H-indol-3-yl)-3-phenyl-propanal (Table 2, entry 5). Prepared
according to the general procedure from cinnamaldehyde (190 µL, 1.50 mmol), 1-methyl-1H-
indole (64µL, 0.50 mmol), TFA (7.7 µL, 0.10 mmol) and (2 S,5S)-5-benzyl-2-tert-butyl-3-
methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.85 mL) and isopropanol (0.15
mL) at −55 °C for 45 h to provide, after silica gel chromatography (10:90 EtOAc/hexanes), the
title compound as a colorless oil (110 mg, 84% yield, 90% ee). IR (film) 3051, 3026, 2945, 2888,
2822, 2733, 1722, 1616, 1604, 1547, 1474, 1429, 1376, 1331, 1245, 1225, 1156, 1131, 1013,
765, 740, 700 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 2.4 Hz, 1H, CHO), 7.43 (dt,
J = 0.9, 8.1 Hz, 1H, ArH), 7.36-7.28 (m, 7H, ArH), 7.04 (ddd, J = 1.2, 6.9, 8.1 Hz, 1H, ArH),
6.88 (s, 1H, NCH), 4.88 (t, J = 7.5 Hz, 1H, ArCH), 3.76 (s, 3H, NCH3), 3.22 (ddd, J = 2.7, 8.4,
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16.5 Hz, 1H, CH2CO); 3.10 (ddd, J = 2.7, 8.4, 16.5 Hz, 1H, CH2CO); 13C NMR (75 MHz,
CDCl3) δ 201.8, 143.5, 137.3, 128.6, 127.6, 126.8, 126.6, 126.4, 121.9, 119.4, 119.0, 116.6,
109.3, 50.0, 37.4, 32.9; HRMS (CI) exact mass calcd for (C15H17NO) requires m/z 263.1310,
found m/z 263.1306. [α]D = + 30.9 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by
HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde, using a Chiracel
AD and AD guard column (3:97 ethanol/hexanes, 1 mL/min); S isomer tr = 48.5 min and R
isomer tr = 38.9 min.
(R)-4-Benzyloxy-3-(1-methyl-1H-indol-3-yl)-butanal (Table 2, entry 4). Prepared
according to the general procedure from 4-benzyloxy-but-2-enal (286 mg, 1.50 mmol), 1-methyl-
1H-indole (64µL, 0.50 mmol), TFA (7.7 µL, 0.10 mmol) and (2 S,5S)-5-benzyl-2-tert-butyl-3-
methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.85 mL) and isopropanol (0.15
mL) at −83 °C for 18.5 h to provide, after silica gel chromatography (50:50 Et2O/hexanes), the
title compound as a colorless oil (134 mg, 84% yield, 96% ee).  IR (film) 3056, 2957, 2894,
2830, 2722, 1717, 1618, 1600, 1582, 1550, 1478, 1451, 1370, 1331, 1309, 1272, 1223, 1173,
1110, 1070, 1024, 772, 740, 714 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.77 (dd, J = 2.1, 2.1 Hz,
1H, CHO), 8.04 (d, J = 7.2 Hz, 2H, ArH), 7.75 (d, J = 8.1 Hz, 1H, ArH), 7.61-724 (m, 5H, ArH),
7.17 (ddd, J = 1.5, 6.6, 8.1 Hz, 1H, ArH), 6.96 (s, 1H, NCH), 4.73 (dd, J = 5.1, 11.1 Hz, 1H,
CH2O), 4.42 (dd, J = 8.7, 11.1 Hz, 1H, CH2O), 4.12 (m, 1H, ArCH), 3.76 (s, 3H, NCH3), 3.06
(ddd, J = 2.1, 6.3, 16.8 Hz, 1H, CH2CO); 2.96 (ddd, J = 2.7, 8.4, 16.8 Hz, 1H, CH2CO); 13C
NMR (75 MHz, CDCl3) δ 201.5, 166.4, 137.1, 133.1, 129.9, 129.6, 128.5, 126.8, 126.4, 122.1,
119.3, 119.0, 112.9, 109.6, 68.1, 46.5, 33.0, 31.2; HRMS (CI) exact mass calcd for (C20H19NO)
requires m/z 321.1365, found m/z 321.1354. [α]D = − 2.0 (c = 1.0, CHCl3).  The enantiomeric
ratio was determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the
aldehyde, using a Chiracel AS and AS guard column (4:96 ethanol/hexanes, 1 mL/min); S isomer
tr = 42.9 min and R isomer tr = 53.2 min.
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(R)-2-(1-Methyl-1H-indol-3-yl)-4-oxo butyric acid methyl ester (Table 2, entry 6).
Prepared according to the general procedure from methyl 4-oxo-butenoate (171 mg, 1.50 mmol),
1-methyl-1H-indole (64µL, 0.50 mmol), TFA (7.7 µL, 0.10 mmol) and (2 S,5S)-5-benzyl-2-tert-
butyl-3-methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.90 mL) and isopropanol
(0.10 mL) at −85 °C for 21 h to provide, after silica gel chromatography (5:47:47
acetone/CH2Cl2/hexanes), the title compound as a colorless oil (109 mg, 89% yield, 91% ee). IR
(film) 2937, 2833, 2729, 1732, 1623, 1545, 1477, 1436, 1379, 1332, 1228, 1171, 1042, 1016,
980, 773, 742 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.81 (s, 1H, CHO), 7.67 (d, J = 8.4 Hz, 1H,
ArH), 7.33-7.23 (m, 2H, ArH), 7.15 (ddd, J = 1.2, 7.6, 7.8 Hz, 1H, ArH), 6.98 (s, 1H, NCH),
4.44 (dd, J = 5.4, 9.3 Hz, 1H, ArH), 3.76 (s, 3H, NCH3), 3.69 (s, 3H, OCH3), 3.47 (dd, J = 9.3,
18.6 Hz, 1H, CH2CO); 2.94 (dd, J = 5.1, 18.3 Hz, 1H, CH2CO); 13C NMR (75 MHz, CDCl3)
δ 200.1, 173.8, 137.0, 126.9, 126.5, 122.1, 119.5, 119.1, 110.8, 109.6, 52.5, 46.8, 36.5, 33.0;
HRMS (CI) exact mass calcd for (C14H15NO3) requires m/z 245.1048, found m/z 153.1151. [α]D =
− 123.6 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC analysis of the
alcohol, obtained by NaBH4 reduction of the aldehyde, using a Chiracel AS and AS guard
column (3:97 isopropanol / hexanes, 1 mL/min); S isomer tr = 71.7 min and R isomer tr = 76.3
min.
(R)-3-(1H-Indol-3-yl)-butanal (Table 3, entry 2).  Prepared according to general
procedure from crotonaldehyde (100 µL, 1.25 mmol), indole (146 mg, 1.25 mmol), 2,4-
dinitrobenzoic acid (53 mg, 0.25 mmol) and (2S , 5S)-5-benzyl-2-tert-butyl-3-methyl-
imidazolidin-4-one (62 mg, 0.25 mmol) in CH2Cl2 (2.25 mL) and isopropanol (0.25 mL) at −60
°C for 19 h at which time an additional 30 µL (0.36 mmol) of crotonaldehyde was added.  The
reaction was allowed to continue stirring for an additional 3 h to provide, after silica gel
chromatography (20:80 EtOAc/hexanes),  the title compound as a colorless oil (168 mg, 72%
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yield, 91% ee). IR (film) 3408, 2962, 2875, 2833, 2729, 1716, 1617, 1451, 1420, 1337, 1223,
1099, 1010, 772, 741 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.77 (dd, J = 2.1, 2.1 Hz, 1H, CHO),
8.15 (s, 1H, NH), 7.68 (dt, J = 0.6, 7.8 Hz, 1H, ArH), 7.35 (dt, J = 1.5, 7.8 Hz, 1H, ArH), 7.27-
7.15 (m, 2H, ArH), 6.94 (d, J = 2.4 Hz, 1H, NCH), 3.68 (dt, J = 7.2, 21 Hz, 1H, ArCH), 2.91
(ddd, J = 2.4, 6.9, 16.2 Hz, 1H, CH2CO); 2.73 (ddd, J = 2.1, 7.2, 16.2 Hz, 1H, CH2CO); 1.47 (d,
J = 6.9 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 203.0, 136.5, 126.1, 122.1, 120.7, 120.1,
119.3, 118.9, 111.4, 50.9, 26.0, 21.6; HRMS (CI) exact mass calcd for (C12H13NO) requires m/z
187.0997, found m/z 153.0993. [α]D = −  2.2 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde,
using a Chiracel OD−H and OD guard column (10:90 ethanol/hexanes, 1 mL/min); S isomer tr =
20.2 min and R isomer tr = 17.6 min.
(R)-3-(1-Allyl-1H-indol-3-yl)-butanal (Table 3, entry 3).  Prepared according to
general procedure from crotonaldehyde (125 µL, 1.50 mmol), 1-allyl-1H-indole (78.5 mg, 0.500
mmol), TFA (7.7 µL, 0.10 mmol) and (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-
one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.90 mL) and isopropanol (0.10 mL) at −72 °C for 21 h to
provide, after silica gel chromatography (7:93 EtOAc/hexanes), the title compound as a colorless
oil (80 mg, 70% yield, 92% ee). IR (film) 3041, 2966, 2919, 2822, 2834, 2712, 1722, 1469,
1375, 1328, 1309, 1262, 192, 1018, 995, 929, 736 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (dd,
J = 2.1, 2.1 Hz, 1H, CHO), 7.64 (dt, J = 0.9, 7.8 Hz, 1H, ArH), 7.33-7.20 (m, 2H, ArH), 7.13
(ddd, J = 0.9, 6.9, 7.8 Hz, 1H, ArH), 6.89 (s, 1H, NCH), 5.98 (ddd, J = 5.4, 9.9, 22.5 Hz, 1H,
CH2CHCH2), 5.20 (dd, J = 1.5, 10.2 Hz, 1H, CH2CHCH2), 5.10 (dt, J = 1.5, 17.1 Hz, 1H
CH2CHCH2), 4.68 (d, J = 5.4 Hz, 2H NCH2), 3.69 (dt, J = 6.9, 21.3 Hz, 1H, ArCH), 2.88 (ddd, J
= 2.4, 6.6, 16.2 Hz, 1H, CH2CO); 2.71 (ddd, J = 2.1, 7.2, 16.2 Hz, 1H, CH2CO); 1.44 (d, J = 6.9
Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 202.8, 136.7, 133.5, 126.8, 124.1, 121.8, 119.3,
119.2, 119.0, 117.4, 109.8, 51.1, 48.9, 26.1, 21.8;  HRMS (CI) exact mass calcd for (C15H17NO)
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requires m/z 227.1310, found m/z 227.1309. [α]D = − 4.4 (c = 1.0, CHCl3).  The enantiomeric
ratio was determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the
aldehyde, using a Chiracel AD and AD guard column (2:98 ethanol/hexanes, 1 mL/min); S
isomer tr = 38.7 min and R isomer tr = 42.2 min.
(R)-3-(1-Benzyl-1H-indol-3-yl)-butanal (Table 3, entry 4).  Prepared according to the
general procedure from crotonaldehyde (125 µL, 1.50 mmol), 1-benzyl-1H-indole (104 mg,
0.500 mmol), 2,4-dinitrobenzoic acid (21.2 mg, 0.100 mmol) and (2S,5S)-5-benzyl-2-tert-butyl-
3-methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.90 mL) and isopropanol (0.10
mL) at −60 °C for 41 h, at which time an additional 125 µL (1.50 mmol) of crotonaldehyde was
added.  The reaction was continued for an additional 70 h, at which time an additional 42 µL
(0.50 mmol) of crotonaldehyde was added.  The reaction was continued at this temperature for
an additional 5 h, at which time the temperature was raised to −40 °C for 2 h, then −10 °C for an
additional 2 h to provide, after silica gel chromatography (15:85 EtOAc/hexanes), the title
compound as a colorless oil (110 mg, 80% yield, 89% ee). IR (film) 3062, 3030, 2965, 2925,
2877, 2820, 2724, 1722, 1613, 1589, 1549, 1496, 1480, 1468, 1452, 1392, 1372, 1356, 1331,
1303, 1251, 1203, 1174, 1017 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 2.4 Hz, 1H,
CHO), 7.66 (dt, J = 0.6, 7.5 Hz, 1H, ArH), 7.33-7.08 (m, 8H, ArH), 6.92 (s, 1H, NCH), 5.28 (s,
2H, NCH2), 3.70 (dt, J = 6.9, 21 Hz, 1H, ArCH), 2.89 (ddd, J = 2.4, 6.6, 16.5 Hz, 1H, CH2CO);
2.72 (ddd, J = 1.8, 7.8, 15.9 Hz, 1H, CH2CO); 1.44 (d, J = 6.9 Hz, 3H, CHCH3); 13C NMR (75
MHz, CDCl3) δ  202.7, 137.5, 131.9, 128.8, 127.6, 126.9, 126.8, 124.6, 122.0, 119.6, 119.3,
119.2, 110.0, 51.2, 50.1, 26.1, 21.0; HRMS (CI) exact mass calcd for (C19H19NO) requires m/z
277.1467, found m/z 277.1464. [α]D = + 3.5 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde,
using a Chiracel AD and AD guard column (2:98 isopropanol / hexanes, 1 mL/min); S isomer tr
= 26.5 min and R isomer tr = 29.5 min.
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(R)-4-Benzyloxy-3-(4-methoxy-1-methyl-1H-indol-3-yl)-butanal (Table 3, entry 6).
Prepared according to the general procedure from 4-benzyloxy-but-2-enal (285 mg, 1.50 mmol),
4-methoxy-1-methyl-1H-indole (80.5 mg, 0.500 mmol), TFA (7.7 µL, 0.10 mmol) and (2S,5S)-
5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2 (0.90 mL)
and isopropanol (0.10 mL) at −87 °C for 19.5 h to provide, after silica gel chromatography
(20:80 EtOAc/hexanes),  the title compound as a colorless oil (158 mg, 90% yield, 94% ee). IR
(film) 3081, 2961, 2850, 2730, 1719, 1608, 1582, 1548, 1501, 1466, 1454, 1424, 1381, 1334,
1321, 1274, 1261, 1180, 1116, 1073, 1026, 782, 714 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.78
(dd, J = 2.4, 2.4 Hz, 1H, CHO), 8.03-8.01 (m, 2H, ArH), 7.59-7.53 (m, 1H, ArH), 7.47-7.41 (m,
2H, ArH), 7.16 (t, J = 8.4 Hz, 1H, ArH), 6.92 (dd, J = 0.6, 8.4 Hz, 1H, ArH), 6.83 (s, 1H, NCH),
6.52 (d, J = 7.5 Hz, 1H, ArH), 4.71 (dd, J = 5.1, 10.5 Hz, 1H, CH2O), 4.50 (dd, J = 8.4, 10.5 Hz,
1H, CH2O), 4.35 (m, 1H, ArCH), 3.94 (s, 1H, OCH3), 3.71 (s, 3H, NCH3), 2.98 (d, J = 2.4 Hz,
1H, CH2CO); 2.96 (d, J = 2.7 Hz, 1H, CH2CO); 13C NMR (75 MHz, CDCl3) δ 202.5, 166.3,
154.2, 133.0, 130.3, 129.6, 128.6, 128.4, 125.4, 122.9, 116.8, 113.6, 102.8, 99.4, 68.8, 55.3, 47.3,
33.2, 32.2; HRMS (CI) exact mass calcd for (C21H21NO4) requires m/z 351.1471, found m/z
351.1466. [α]D = −13.9 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by HPLC
analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde, using a Chiracel AD and
AD guard column (4:96 ethanol/hexanes, 1 mL/min); S isomer tr = 58.7 min and R isomer tr =
47.5 min.
(R)-4-Benzyoxy-3-(4-methyl-1H-indol-3-yl)-butanal (Table 3, entry 5). Prepared
according to the general procedure from benzoic acid 4-benzyloxy-but-enal (143 mg, 0.750
mmol), 4-methyl-1H-indole (80.5 mg, 0.500 mmol), 2,4-dinitrobenzoic acid (21.2 mg, 0.100
mmol) and (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in
CH2Cl2 (0.90 mL) and isopropanol (0.10 mL) at −60 °C for 2.5 h to provide, after silica gel
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chromatography (15:85 EtOAc/hexanes), the title compound as a colorless oil (150 mg, 94%
yield, 94% ee) after silica gel chromatography in 15% EtOAc / hexanes. IR (film) 3406, 2947,
2923, 2843, 2738, 1717, 1620, 1604, 1584, 1451, 1411, 1383, 1344, 1315, 1271, 1178, 1114,
1066, 1226, 969 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.82 (dd, J = 2.1, 2.1 Hz, 1H, CHO), 8.14
(s, 1H, NH), 8.02 (dt, J = 1.5, 7.2 Hz, 2H, ArH), 7.58 (tt, J = 1.5, 6.6 Hz, 1H, ArH), 7.45 (tt, J =
1.2, 6.9 Hz, 2H, ArH), 7.24-7.08 (m, 3H, ArH, NCH), 6.91 (dt, J = 0.9, 7.2 Hz, 1H, ArH), 4.74
(dd, J = 4.2, 10.5 Hz, 1H, CH2O), 4.52-4.43 (m, 1H, ArCH), 4.32 (dd, J = 8.4, 10.8 Hz, 1H,
CH2O), 3.05 (ddd, J = 2.1, 6.9, 16.8 Hz, 1H, CH2CO); 2.95 (ddd, J = 2.1, 7.8, 16.8 Hz, 1H,
CH2CO), 2.82 (s, 3H, ArCH3);  13C NMR (75 MHz, CDCl3) δ 201.3, 166.3, 136.5, 133.2, 130.5,
130.0, 129.7, 128.5, 125.1, 122.6, 122.1, 121.7, 115.8, 109.4, 68.9, 47.8, 31.7, 21.0; HRMS (CI)
exact mass calcd for (C20H19NO3) requires m/z 321.1365, found m/z 321.1353. [α]D = −26.6 (c =
1.0, CHCl3).  The enantiomeric ratio was determined by HPLC analysis of the alcohol, obtained
by NaBH4 reduction of the aldehyde, using a Chiracel AD and AD guard column (10:90
ethanol/hexanes, 1 mL/min); S isomer tr = 47.8 min and R isomer tr = 42.4 min.
(R)-4-Benzyloxy-3-(6-chloro-1H-indol-3-yl)-butanal (Table 3, entry 7). Prepared
according to the general procedure from 4-benzyloxy-but-2-enal (143 mg, 0.750 mmol), 6-
chloro-1H-indole (75.8, 0.500 mmol), 2,4-dinitrobenzoic acid (21.2 mg, 0.100 mmol) and
(2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (24.6 mg, 0.100 mmol) in CH2Cl2
(0.90 mL) and isopropanol (0.10 mL) at -60 °C for 12.75 h to provide, after silica gel
chromatography (CH2Cl2), the title compound as a colorless oil (124 mg, 73% yield, 97% ee)
after silica gel chromatography in CH2Cl2. IR (film) 3383, 2953, 2930, 2834, 2734, 1718, 1623,
1603, 1548, 1453, 1403, 1378, 1273, 1184, 1104, 1069, 1019, 909, 804, 774, 714 cm-1; 1H NMR
(300 MHz, CDCl3) δ 9.77 (dd, J = 1.8, 1.8 Hz, 1H, CHO), 8.15 (s, 1H, NH), 8.02-7.99 (m, 2H,
ArH), 7.65 (dd, J = 0.6, 8.7 Hz, 1H, ArH), 7.58 (tt, J = 1.5, 6.6 Hz, 1H, ArH), 7.48-7.42 (m, 2H,
ArH), 7.37 (d, J = 1.8 Hz, 1H NCH), 7.12 (dt, J = 2.1, 8.7 Hz, 2H, ArH), 4.70 (dd, J = 5.1, 10.8
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Hz, 1H, CH2O), 4.42 (dd, J = 8.4, 11.1 Hz, 1H, CH2O), 4.08 (m, 1H, ArCH), 3.06 (ddd, J = 1.8,
6.3, 16.8 Hz, 1H, CH2CO); 2.95 (ddd, J = 2.1, 7.8, 16.5 Hz, 1H, CH2CO); 13C NMR (75 MHz,
CDCl3) δ 200.9, 166.5, 136.7, 135.4, 133.2, 129.9, 129.6, 128.5. 125.1, 122.3, 120.7, 119.8,
115.0, 111.4, 67.8, 46.5, 31.0; HRMS (CI) exact mass calcd for (C19H16ClNO3) requires m/z
341.0819, found m/z 341.0814. [α]D = −3.3 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde,
using a Chiracel AD and AD guard column (10:90 ethanol/hexanes, 1 mL/min); S isomer tr =
38.8 min and R isomer tr = 43.3 min.
(R)-3-[1-(4-Bromo-benzyl)-5-methoxy-2-methyl-1H-indol-3-yl]-butanal (eq 3).  To 1-
(4-bromo-benzyl)-5-methoxy-2-methyl-1H-indole (110 mg, 0.333 mmol) in a 2-dram amber vial
was added CH2Cl2 (0.60 mL), isopropanol (0.066 mL), dichloroacetic acid (5.5 µL, 0.066 mmol)
and (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (16.4 mg, 0.066 mmol).  This
solution was stirred for 10 min at room temperature, then placed in a −70 °C bath for an
additional 10 min.  At this time, crotonaldehyde (82 µL, 1.0 mmol) was added and the reaction
was stirred at −70 °C for 9 h.  The reaction mixture was then transferred cold through a silica
plug into a flask and concentrated to provide, after silica gel chromatography (20:80
EtOAc/hexanes), the title compound as a colorless oil (111 mg, 84% yield, 87% ee). IR (film)
2930, 2823, 2730, 1722, 1618, 1581, 1530, 1483, 1452, 1405, 1229, 1156, 1073, 1037, 1011,
902, 798, 476 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.69 (dd, J = 1.8, 1.8 Hz, 1H, CHO), 7.38 (dt,
J = 2.4, 9.0 Hz, 2H, ArH), 7.12 (d, J = 2.1 Hz, 1H, ArH), 7.05 (d, J = 9.0, 1H, ArH), 6.79-6.75
(m, 3H, ArH), 5.19 (s, 2H NCH2), 3.88 (s, 3H, OCH3), 3.66 (dt, J = 7.2, 22.2 Hz, 1H ArCH),
3.02 (ddd, J = 1.8, 8.1, 16.5 Hz, 1H, CH2CO); 2.85 (ddd, J = 2.1, 6.6, 16.5 Hz, 1H, CH2CO);
2.30 (s, 3H, ArCH3) 1.48 (d, J = 7.2 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 202.5,
153.6, 137.0, 132.7, 132.0, 131.9, 127.6, 126.6, 121.1, 114.5, 110.0, 109.8, 102.3, 56.2, 50.6,
46.2, 26.4, 21.4, 10.9; HRMS (CI) exact mass calcd for (C21H22BrNO2) requires m/z 399.0834,
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found m/z 399.0833. [α]D = −20.8 (c = 1.0, CHCl3).  The enantiomeric ratio was determined by
HPLC analysis of the alcohol, obtained by NaBH4 reduction of the aldehyde, using a Chiracel
OD−H and OD guard column (4:96 ethanol/hexanes, 1 mL/min); S isomer tr = 45.1 min and R
isomer tr = 35.9 min.
(R)-3-[1-(4-Bromo-benzyl)-5-methoxy-2-methyl-1H-indol-3-yl]-butyric acid (eq 3).
A solution of (R)-3-[1-(4-Bromo-benzyl)-5-methoxy-2-methyl-1H-indol-3-yl]-butanal (110 mg,
0.250 mmol) and silver nitrate (59.7mg, 0.275mmol) in 1.3ml absolute ethanol was treated with
a solution of 5N NaOH in ethanol (1:5, 0.9ml, 0.75 mmol NaOH).  After 45 min this was treated
with 10ml water, acidified to pH 3 and extracted with CHCl3 (5x20ml) rinsing each extract with
brine.  The combined organics were dried over Na2SO4 and concentated in vacuo to provide,
after silica gel chromatography the title compound as a pale yellow solid (101 mg, 97% yield).
IR (film) 3425, 2961, 2934, 2833, 1706, 1483, 1451, 1405, 1228, 1156, 1010, 796, 755 cm-1; 1H
NMR (300 MHz, CDCl3) δ 7.36 (d, J = 9.0 Hz, 2H, ArH), 7.11 (d, J = 2.4 Hz, 1H, ArH), 7.04
(d, J = 8.7, 1H, ArH), 6.77-6.73 (m, 3H, ArH), 5.18 (s, 2H NCH2), 3.86 (s, 3H, OCH3), 3.56 (dt,
J = 7.2, 21.9 Hz, 1H ArCH), 2.86 (d, J = 3.6 Hz, 1H, CH2CO); 2.83 (d, J = 3.3 Hz, 1H, CH2CO);
2.27 (s, 3H, ArCH3) 1.49 (d, J = 7.2 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 178.0,
153.7, 137.3, 133.8, 133.0, 132.0, 127.7, 126.7, 121.2, 118.8, 114.6, 110.1, 109.9, 102.4, 56.3,
46.3, 41.5, 28.6, 21.1, 10.9; HRMS (CI) exact mass calcd for (C21H23BrNO3) (M+1) requires m/z
416.0861, found m/z 416.0867. [α]D = −30.9 (c = 1.0, CHCl3).
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Determination of absolute stereochemistry
Determination of the absolute stereochemistry of (R)-3-(1H-indol-3-yl)-butanal by
correlation to (S)-3-(1H-indol-3-yl)-butyric acid methyl ester.3 3-(1H-Indol-3-yl)-butanal
(130 mg, 0.690 mmol) was dissolved in tert-butyl alcohol (27 mL) and 2-methyl-2-butene (4.7
mL) and subsequently was stirred for 10 min.  To this solution was added an aqueous solution
(4.7 mL) of NaClO2 (75 mg, 0.83 mmol) and NaH2PO4 (115 mg, 0.830 mmol) in one portion.
The reaction mixture was stirred at room temperature for 12 h.  The organics were removed by
concentrating in vacuo.  The residue was diluted with 10 mL of H2O, and adjusted to a neutral
pH with 1M HCl.  Extraction with EtOAc (3x10 mL), drying over Na2SO4, and concentration in
vacuo provided 3-(1H-indol-3-yl)-butanoic acid.  TMS-diazomethane was added dropwise to a
solution of the crude 3-(1H-indol-3-yl)-butanoic acid in methanol (7 mL) until a yellow color
persisted.  The residual TMS-diazomethane was quenched by the dropwise addition of acetic
acid until the yellow color disappeared. The reaction was then treated with an excess of saturated
aqueous sodium bicarbonate, extracted with Et2O (3 x 20ml), dried over Na2SO4 and purified by
silica gel chromatography (20:80 EtOAc/hexanes to provide (R)-3-(1H-indol-3-yl)-butyric acid
methyl ester. [α]D = −7.6 (c = 1.0, benzene); reported rotation for (S)-3-(1H-indol-3-yl)-butyric
acid methyl ester [α]D = + 10.9 (c = 2.12, benzene).
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Determination of the absolute stereochemistry of (R)-3-(1-Benzyl-1H-indol-3-yl)-
butanal by correlation to (R)-3-(1H-indol-3-yl)-butanal. (R)-3-(1H-Indol-3-yl)-butanal (89.5
mg, 0.479 mmol) was treated with ethylene glycol (130 µL, 2.4 mmol) and a catalytic amount of
p-TSA in CH2Cl2 (2 mL).  The reaction was stirred at room temperature for 12 h, at which time
the organics were removed in vacuo.  The solution was diluted with H2O (10 mL) and extracted
with Et2O (3x20 mL).  The collected organics where washed with brine, dried over Na2SO4 and
concentrated in vacuo to provide (R)-3-(2-[1,3]dioxolan-2-yl-1-methyl-ethyl)-1H-indole (15.7
mg, 0.0680 mmol) after silica gel chromatography (20:80 EtOAc/hexanes). This residual
material was then exposed to 1 mL of DMSO, finely crushed KOH (15.3 mg, 0.272 mmol), and
benzyl bromide (12 µL, 0.13 mmol) at 0°C, then the solution was allowed to warm to room
temperature and stirred for 12 h.  The reaction was then treated with water (10ml), and extracted
with Et2O (2x20ml).  The aqueous layer was acidifid to pH 4, extracted with Et2O 3x20ml), dried
over Na2SO4 and concentrated in vacuo to provide 14.7 mg of (R)-1-benzyl-3-(2-[1,3]dioxolan-2-
yl-1-methyl)-1H-indole after preparative TLC (20:80 EtOAc/hexanes).  The benzylated product
was then refluxed with a catalytic amount of p-TSA in H2O (1 mL) / acetone (2 mL) overnight.
The reaction mixture was diluted with H2O (5 mL), and extracted with Et2O (3x10 mL).  The
collected organics were washed with brine, dried over Na2SO4 and concentrated in vacuo to
provide (R)-3-(1-benzyl-1H-indol-3-yl)-butanal (5.5 mg, 0.020 mmol) after preparative TLC.
[α]D = + 3.8 (c = 1.0, CHCl3); reported rotation for (R)-3-(1-benzyl-1H-indol-3-yl)-butanal [α]D
= + 3.5 (c = 1.0, CHCl3).
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 Determination of the absolute stereochemistry of (R)-3-(1-methyl-1H-indol-3-yl)-
butanal by correlation to (R)-3-(1H-indol-3-yl)-butanal.  (R)-3-(1H-Indol-3-yl)-butanal (236
mg, 1.26 mmol) was dissolved in methanol (15 mL) and treated with trimethyl orthoformate (275
µl, 2.50 mmol) and a catalytic amount of p-TSA.  The reaction was stirred at room temperature
for 3 hours, at which time H2O (10 mL) was added and the reaction was extracted with ether
(3x20 mL).  The collected organics were rinsed with brine, dried over Na2SO4, and concentrated
in vacuo to provide 3-(3,3-dimethoxy-1-methyl-propyl)-1H-indole (228 mg, 1.17 mmol). 3-(3,3-
dimethoxy-1-methyl-propyl)-1H-indole (39.9 mg, 0.171 mmol) was dissolved in a KOH (38.4
mg, 0.684 mmol) / DMSO (2 mL) solution and allowed to stir at 0°C for 10 min, at which time
dimethyl sulfate (32.5 µl, 0.340 mmol) was added and the reaction was allowed to warm to room
temperature.  The reaction was left to stir at room temperature until it appeared done by TLC.
The reaction was quenched with H2O (1 mL) and brought to a neutral pH with dropwise addition
of 1M HCl.  The solution was extracted with Et2O (3x5 mL), and the collected organics were
rinsed with brine, dried over Na2SO4, and concentrated in vacuo to provide 3-(3,3-dimethoxy-1-
methyl-propyl)-1-methyl-indole. This crude residual material was dissolved in THF (5 mL) and
1M HCl (1 mL) to give (R)-3-(1-methyl-1H-indol-3-yl)-butanal (1.9 mg, 0.0094 mmol) after
preparative TLC (25:75 EtOAc/hexanes). .  [α]D = −4.1 (c = 1.0, CHCl3); reported rotation for
(R)-3-(1-methyl-1H-indol-3-yl)-butanal [α]D = −4.2 (c = 1.0, CHCl3).
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Determination of the absolute stereochemistry (R)-4-benzyloxy-3-(1-methyl-1H-
indol-3-yl)-butanal by correlation to (R)-3-(1H-indol-3-yl)-butanal.  (R)-Benzoic acid 2-(1-
methyl-1H-indol-3-yl)-4-oxo-butyt ester (1.65g, 5.10 mmol) was dissolved in CH2Cl2 (50 mL).
This solution was treated with p-TSA (20 mg) and ethylene glycol (1.4 mL, 26 mmol).  The
reaction was stirred at room temperature overnight, at which time the organics were removed in
vacuo.  The solution was diluted with H2O (10 mL) and extracted with Et2O (3x20 mL).  The
collected organics were washed with brine, dried over Na2SO4 and concentrated in vacuo to
provide (R)-benzoic acid 3-[1,3]dioxolan-2-yl-2-(1-methyl-1H-indol-3-yl)-propyl ester.  The
unpurified product was dissolved in MeOH/THF (18 mL / 18 mL) and allowed to stir at room
temperature for 10 min.  To this was added a 4% NaOH / MeOH (18 mL) solution.  The reaction
was allowed to stir at room temperature for 1 h. The solution was diluted with H2O (10 mL) and
extracted with Et2O (3x20 mL).  The collected organics were washed with brine, dried over
Na2SO4 and concentrated in vacuo to provide (R)-3-[1,3]dioxolan-2-yl-2-(1-methyl-1H-indol-3-
yl)-propan-1-ol (600 mg, 2.30 mmol) after silica gel chromatography (50:50 Et2O/hexanes). 50%
Et2O / hexanes).  (R)-3-[1,3]Dioxolan-2-yl-2-(1-methyl-1H-indol-3-yl)-propan-1-ol (69.5 mg,
0.267 mmol) was dissolved in CH2Cl2 (8 mL) and Et3N (56 µl, 0.40 mmol).  The reaction was
cooled to 0 °C and treated with methanesulfonyl chloride (31 µl, 0.40 mmol).  The reaction
stirred for 1.5 h at this temperature then was allowed to warm to room temperature and stirred for
an additional 10 min.  The solution was diluted with H2O (5 mL) and extracted with Et2O (3x10
mL).  The collected organics were washed with brine, dried over Na2SO4 and concentrated in
vacuo to provide (R)-methanesulfonic acid 3-[1,3]dioxolan-2-yl-2-(1-methyl-1H-indol-3-yl)-
propyl ester.  Deoxygenation was performed following the method of Holder and Matturro.4  The
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unpurified material was dissolved in THF (2.7 mL) and the system was purged with an inert
nitrogen atmosphere.  Lithium triethylborohydride (560 µl, 1M solution in THF) was added in
one portion and the reaction was allowed to reflux for 1 h under an nitrogen.  The system was
allowed to come to room temperature and was then cooled to 0 °C via an ice bath.  Excess
hydride was quenched by the dropwise addition of H2O.  Organoboranes were oxidized by
adding 190 µl of a 3N NaOH solution followed by slow dropwise addition of 115 µl of 50%
H2O2.  The ice bath was removed and the reaction mixture was allowed to reflux for an
additional hour.  After cooling to room temperature, the mixture was diluted with 2.7 mL H2O
and extracted with pentane.  The collected pentane layers were washed with H2O, dried with
MgSO4, and concentrated in vacuo to provide (R)-3-(2-[1,3]dioxolan-2-yl-1-methyl-ethyl)-1-
methyl-1H-indole.  The unpurified material was dissolved in 8 ml acetone and 2 ml H2O , treated
with PPTS and warmed to reflux for 24 h.  The reaction was diluted with H2O (5 mL) and
extracted with Et2O (3x10 mL).  The collected organics were washed with brine, dried over
Na2SO4 and concentrated in vacuo to provide  (R)-3-(1-methyl-1H-indol-3-yl)-butanal after
preparative TLC (benzene).  [α]D = −4.6 (c = 1.0, CHCl3); reported rotation for (R)-3-(1-methyl-
1H-indol-3-yl)-butanal [α]D = −4.2 (c = 1.0, CHCl3).
